Cannabidiol Supplements in Romania: Bridging the Gap Between Marketed Claims and Clinical Reality
In recent years, the European market, including Romania, has witnessed a significant increase in the promotion of cannabidiol (CBD)-based products, often presented as effective treatments for various health conditions. This study investigates the inconsistencies between the health claims associated...
Saved in:
| Main Authors: | Corina Andrei, George Mihai Nitulescu, Georgiana Nitulescu, Anca Zanfirescu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Pharmacy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2226-4787/12/6/176 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research and Clinical Practice Involving the Use of <i>Cannabis</i> Products, with Emphasis on Cannabidiol: A Narrative Review
by: João Luís Q. Simei, et al.
Published: (2024-12-01) -
Safety of synthetic cannabidiol as a novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2025-07-01) -
3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract
by: Anna Gościniak, et al.
Published: (2024-11-01) -
Comparative Analysis of Adverse Effects: Protein Kinase Inhibitors Versus Traditional Anticancer Therapies
by: Ioana Lavinia Radulian, et al.
Published: (2025-04-01) -
Statistical and Clustering Analysis of Safety Profiles of FDA-Approved Protein Kinase Inhibitors
by: Ioana Lavinia Radulian, et al.
Published: (2024-12-01)